COMMENTARY
ASCA
ASCA: genetic marker, predictor of disease, or marker of a response to an environmental antigen?
Correspondence to:
Correspondence to:
Professor F Seibold
Department of Gastroenterology, Inselspital, Freiburgstrasse, 3010 Bern, Switzerland; frank.seibold@insel.ch
Anti-Saccharomyces cerevisiae antibodies (ASCA) may be a marker of an immune response to an environmental antigen that occurs in the context of early stage Crohns disease
Keywords: anti-Saccharomyces cerevisiae antibodies; antineutrophil cytoplasmic antibodies; Crohns disease; ulcerative colitis
| The first 150 words of the full text of this article appear below. |
The presence of antibodies against the yeast Saccharomyces cerevisiae (ASCA) and against neutrophils (pANCA) has been used as diagnostic serological markers for inflammatory bowel disease (IBD) for many years. The combination of a positive ASCA test with a negative pANCA test has a positive predictive value of 96% and a specificity of 97% for Crohns disease (CD).1 However, both antibodies have been found in other diseases, such as autoimmune liver disease, primary sclerosing cholangitis (pANCA), and in gluten sensitive enteropathy (ASCA). Therefore, their role as diagnostic serological markers for IBD seems to be limited.
Antibody determination is of interest in patients with indeterminate colitis. However, almost 50% of these patients do not develop ASCA or pANCA antibodies whereas in antibody positive patients, ASCA+/pANCA predicts CD in 80% of patients with indeterminate colitis and ASCA/pANCA+ predicts ulcerative colitis (UC) in 64%.2
Generation of both antibodies is poorly understood. Several studies
Relevant Article
- Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease
- E Israeli, I Grotto, B Gilburd, R D Balicer, E Goldin, A Wiik, and Y Shoenfeld
Gut 2005 54: 1232-1236.[Abstract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
